Vnitr Lek 2018, 64(5):559-563 | DOI: 10.36290/vnl.2018.078

Investigation of congenital thrombophilic conditions: when, in whom, focusing on what or not at all?

Petr Dulíček*, Eva Ivanová, Zuzana Fiedlerová
IV. interní hematologická klinika LF UK a FN Hradec Králové

Venous thromboembolism is a multifactorial disease. Inherited thrombophilia is linked with increased risk of VTE and we know about them more than 50 years. Through a robust thrombophilia work-up in the end of millenium, the criteria for testing have significantly gone down. It is associated with increased amount of information about clinical consequence of testing. We discuss current recommendations not only in the literature, but also in our clinic.

Keywords: criteria for testing; thrombophilia; venous thromboembolism

Received: December 11, 2017; Accepted: March 17, 2018; Published: May 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dulíček P, Ivanová E, Fiedlerová Z. Investigation of congenital thrombophilic conditions: when, in whom, focusing on what or not at all? Vnitr Lek. 2018;64(5):559-563. doi: 10.36290/vnl.2018.078.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Nordsrtöm M, Lindblad B, Bergvist D et al. A prospective study of the incidence of deep vein thrombosis with a defined urban population. J Intern Med 1992; 232(2): 155-160. Go to original source... Go to PubMed...
    2. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-530. Go to original source...
    3. Griffin JH, Evatt B, Zimmerman TS et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68(5): 1370-1373. Go to original source... Go to PubMed...
    4. Schwarz HP, Fisher M, Hapmeier P et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64(6): 1297-1300. Go to original source...
    5. Comp PC, Nixon RR, Cooper MR et al. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74(6): 2082. Dostupné z DOI: <http://dx.doi.org/10.1172/JCI111632>. Go to original source... Go to PubMed...
    6. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C; prediction of a cofactor to activated protein C. Proc Natl Scad Sci USA 1993; 90(3): 1004-1008. Go to original source... Go to PubMed...
    7. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369(6475): 64-67. Dostupné z DOI: <http://dx.doi.org/10.1038/369064a0>. Go to original source... Go to PubMed...
    8. Poort SR, Rosendaal FR, Reitsma PH et al. A common genetic variation in the 3'-untraslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an in venous thrombosis and an increase in venous thrombosis. Blood 1996; 88(10): 3698-3703. Go to original source...
    9. Poul H, Kessler P. Trombofilní stavy: význam pro prevenci a léčbu žilního tromboembolizmu. Vnitř Lék 2009; 55(3): 242-252. Go to PubMed...
    10. Čingerová L, Kučeráková M. Thrombophilia. Vnitř Lék 2016; 62(12): 985-989. Go to PubMed...
    11. Chrobák L, Dulíček P. Thrombophilia states. Vnitř Lék 1998; 44(8): 481-486. Go to PubMed...
    12. Koster T, Rosendaal FR, de Ronde H et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342(8886-8887): 1503-1506. Go to original source... Go to PubMed...
    13. Martinelli I, Mannucci PM, De Stefano V et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92(7): 2353-2358. Go to original source...
    14. Simioni P, Sanson BJ, Prandoni P et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Tromb Haemost 1999; 81(2): 198-202. Go to original source... Go to PubMed...
    15. Middeldorp S, Henkens CM, Koopman MM et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998; 128(1): 15-20. Go to original source... Go to PubMed...
    16. Christiaens L. Idiopathic venous thromboembolic disease. Risk factors for recurrence in 2006. Arch Mal Coeur Vaiss 2007; 100(2): 133-138. Go to PubMed...
    17. Linnemann B, Zgouras D, Schindewolf M et al. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Blood Coagul Fibrinolysis 2008; 19(2): 159-165. Dostupné z DOI: <http://dx.doi.org/10.1097/MBC.0b013e3282f54558>. Go to original source... Go to PubMed...
    18. Dalen JE. Should patients with venous thromboembolism be screened for thrombophilia? Am J Med 2008; 121(6): 458-463. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2007.10.042>. Go to original source... Go to PubMed...
    19. Dulíček P, Malý J, Pešavová L. Prevalence of inherited thrombophilia in young thrombosis patients from the East Bohemian region. Blood Coagul Fibrinolysis 2002; 13(6): 569-573. Go to original source... Go to PubMed...
    20. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3(2): 292-299. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1538-7836.2005.01141.x>. Go to original source... Go to PubMed...
    21. Bezemer ID, Doggen CJ, Vos HL et al. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med 2007; 167(5): 497-501. Dostupné z DOI: <http://dx.doi.org/10.1001/archinte.167.5.497>. Go to original source... Go to PubMed...
    22. Croles FN, Nasserinejad K, Duvekot JJ et al. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ 2017; 359: j4452. Dostupné z DOI: <http://dx.doi.org/10.1136/bmj.j4452.10.1136/bmj.j4452>. Go to original source... Go to PubMed...
    23. Wu O, Robertson L, Twaddle S et al. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol 2005; 131(1): 80-90. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2141.2005.05715.x>. Go to original source... Go to PubMed...
    24. Baglin T, Gray E, Greaves M et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010; 149(2): 209-220. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2141.2009.08022.x>. Go to original source... Go to PubMed...
    25. Berse B, Lynch JA, Bowen S et al. In Reference to: "Cost and Utility of Thrombophilia Testing". J Hosp Med 2017; 12(9): 783. Dostupné z DOI: <http://dx.doi.org/10.12788/jhm.2818>. Go to original source... Go to PubMed...
    26. Cox N, Johnson SA, Vasquez S. Patterns and Appropriateness of Thrombophilia Testing in an Academic Medical Center. J Hosp Med 2017; 12(9): 705-709. Dostupné z DOI: <http://dx.doi.org/10.12788/jhm.2804>. Go to original source... Go to PubMed...
    27. Colucci G, Tsakiris DA. Thrombophilia Screening: Universal, Selected, or Neither? Clin Appl Thromb Hemost 2017; 23(8): 893-899. Dostupné z DOI: <http://dx.doi.org/10.1177/1076029616683803>. Go to original source... Go to PubMed...
    28. Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematology Am Soc Hematol Educ Program 2016; 2016(1): 1-9. Dostupné z DOI: <http://dx.doi.org/10.1182/asheducation-2016.1.1>. Go to original source... Go to PubMed...
    29. Linnemann B. Testing for thrombophilia in patients with venous thromboembolism - why and whom to test? Dtsch Med wochenschr 2016; 141(20): 1432-1435. Dostupné z DOI: <http://dx.doi.org/10.1055/s-0042-114094>. Go to original source... Go to PubMed...
    30. Pruthi RK. Optima utilization of thrombophilia testing. Int J Lab Hematol 2017; 39(Suppl 1): S104-S110. Dostupné z DOI: <http://dx.doi.org/10.1111/ijlh.12672>. Go to original source... Go to PubMed...
    31. Connors JM. Thrombophilia testing and Venous Thrombosis. N Engl J Med 2017; 377(12): 1177-1187. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1700365>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.